surmount 4 tirzepatide ECO 2026: SURMOUNT-MAINTAIN proves sustains weight loss long term Just sharing the published Surmount

14.2 Weight Reduction and Long-term Maintenance Studies in Adults with Obesity or Overweight Overview of Clinical Trials in Adults The efficacy of WEGOVY once weekly subcutaneous injection for weight reduction and long-term maintenance of body weight in conjunction with a reduced-calorie diet and increased physical activity were studied in three 68-week, randomized, double-blind, placebo-controlled trials

Injection Therapy Recovery Most can resume their regular activities right after treatment, with no downtime required

Common effects: Dizziness Hypotension Fatigue Hyperkalemia Headache Less common but notable: Renal impairment Angioedema (rare) GI upset Contraindications Pregnancy (teratogenic) Bilateral renal artery stenosis Severe hepatic impairment History of angioedema with ARBs (rare) Cautions Monitor potassium & creatinine Use carefully with: Potassium-sparing diuretics NSAIDs ACE inhibitors Lithium Benefits Over ACE Inhibitors No dry cough Lower chance of angioedema Good renal protection Patient Advice Take at the same time each day Report dizziness or swelling Avoid potassium supplements unless advised Regular kidney function and BP monitoring Brand Names Cozaar Losacar Aprovasc (with amlodipine) Hyzaar (with hydrochlorothiazide) To view or add a comment, sign in What is Diabetic Ketoacidosis

11 KoeberleS

the applicable beyond-use period is defined by the licensed product's SmPC and local pharmacy policy

Whether you are using specialized peptides or standard medications, it is vital to discern between a true clinical pregnancy and a biochemical error